Shandong Forida Pharmaceutical Group Company was founded on April 17, 1993, formerly known as Shandong Province Biochemical Drugs Company, which is subordinate to Shandong Commercial Group Company Limited, and is a modern large-scale high-tech industrial group integrating science, industry and trade. Based on the technology of Shandong Academy of Pharmaceutical Sciences, Shandong Forida Pharmaceutical Group has formed a comprehensive pharmaceutical enterprise group integrating science, industry and trade, based on the product development of pharmaceuticals, health food and cosmetics related to human health. With its own intellectual property technology, the pharmaceutical group has successively set up a number of high-tech enterprises, such as Shandong Dr. Bao Lun (former Zhengda) Forida Pharmaceutical Company Limited, Shandong Forida Biomedical Company Limited, Shandong Mingren Forida Pharmaceutical Company Limited, Shandong Forida Bioengineering Company Limited, Shandong Forida Biotechnology Company Limited, and so on. Ltd. and Shandong Forida Bio-engineering Co., Ltd. and many other high-tech enterprises, which are involved in pharmaceuticals, health food, cosmetics, medical devices and raw materials, etc., and owns "Rensu", "Runjie", "Shipuite", "In 2011, the sales revenue of Forida Pharmaceutical Group amounted to 1.73 billion yuan, and the profit and tax amounted to 368 million yuan. Ltd. has developed into the largest ophthalmic drug production base in China, and its products have occupied 20% of the domestic ophthalmic drug market share. Shandong Forida Bio-pharmaceutical Co., Ltd. with the fermentation method of production of hyaluronic acid technology advantage, its products not only in the domestic market to occupy a major market share, but also exported to Japan, the United States, Europe, South Korea and other international markets.